|
Orion, Nycomed sign deal for Easyhaler
Pharmaceutical Business Review Orion, an European R&D-based pharmaceutical and diagnostic company, has signed a deal with Nycomed to jointly market Easyhaler combination products as a treatment for asthma and chronic obstructive pulmonary disease (COPD) in some of the European … Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPD Nycomed and Orion to sell generic Advair and Symbicort |
View full post on asthma – Google News